SOD2 and prostate adenocarcinoma: The GEPIA platform was used to measure the correlation between the antioxidant protein expression: Superoxide Dismutase 1 and 2 (SOD1 and SOD2) and peroxiredoxin 3 (PRDX3) with the NEK6 gene expression in prostate adenocarcinoma samples.